Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Understand why avoiding delays in retirement planning is crucial for your financial security. Make informed decisions for your future.
26,609 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Progressive isn’t just selling policies; it’s harnessing driving data to price risk more precisely. That quiet edge c...
Carvana’s stock run looked extraordinary, up 4,300% in three years. But the strongest buy signal wasn’t the hype—it w...
Apyx Medical (APYX) 2026 is shaping up as a pivotal year for investors. This guide breaks down how to read the Q1 tra...
A major adviser boosted its stake in Savara by more than a million shares during the latest quarter, wading into a bi...
Oil markets are in flux, and Occidental faces a pivotal year. This guide breaks down what to expect from occidental (...
Investors are watching PLBY closely as plby (plby) 2026 earnings unfold. This article breaks down Q1 results, evaluat...
Alphabet is stepping up its AI game, signaling big potential and bigger risks for investors. This piece breaks down w...
As KBR prepares to unveil its Q4 2025 results, investors should focus on backlog, margins, and free cash flow. This g...
A hedge fund famous for bold bets shows a striking concentration: nearly half of its $14 billion stock portfolio sits...
Bitcoin bounced off a rough patch, but a veteran trader cautions that a final flush could wipe out late buyers. Analy...
A broad selloff descends into rout in South Korea, sending the KOSPI to its worst daily decline in 16 years. Margin c...